Calreticulin exposure dictates the immunogenicity of cancer cell death
- 24 December 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 13 (1), 54-61
- https://doi.org/10.1038/nm1523
Abstract
Anthracyclin-treated tumor cells are particularly effective in eliciting an anticancer immune response, whereas other DNA-damaging agents such as etoposide and mitomycin C do not induce immunogenic cell death. Here we show that anthracyclins induce the rapid, preapoptotic translocation of calreticulin (CRT) to the cell surface. Blockade or knockdown of CRT suppressed the phagocytosis of anthracyclin-treated tumor cells by dendritic cells and abolished their immunogenicity in mice. The anthracyclin-induced CRT translocation was mimicked by inhibition of the protein phosphatase 1/GADD34 complex. Administration of recombinant CRT or inhibitors of protein phosphatase 1/GADD34 restored the immunogenicity of cell death elicited by etoposide and mitomycin C, and enhanced their antitumor effects in vivo. These data identify CRT as a key feature determining anticancer immune responses and delineate a possible strategy for immunogenic chemotherapy.Keywords
This publication has 33 references indexed in Scilit:
- Cancer despite immunosurveillance: immunoselection and immunosubversionNature Reviews Immunology, 2006
- Doxorubicin prevents endoplasmic reticulum stress-induced apoptosisBiochemical and Biophysical Research Communications, 2006
- Caspase-dependent immunogenicity of doxorubicin-induced tumor cell deathThe Journal of Experimental Medicine, 2005
- Apoptotic Cells Deliver Processed Antigen to Dendritic Cells for Cross-PresentationPLoS Biology, 2005
- Calreticulin Promotes Folding of Functional Human Leukocyte Antigen Class I Molecules in VitroPublished by Elsevier BV ,2004
- Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulinVaccine, 2004
- Inflammation and necrosis promote tumour growthNature Reviews Immunology, 2004
- Death and anti-death: tumour resistance to apoptosisNature Reviews Cancer, 2002
- A Model for Binding of Structurally Diverse Natural Product Inhibitors of Protein Phosphatases PP1 and PP2AJournal of Medicinal Chemistry, 1997
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995